Home » Topics » Regulatory

Regulatory
RSS

Retisert launched for chronic noninfectious uveitis

July 6, 2005

New approval for Topamax

July 5, 2005

Avelox approved for complicated skin and skin structure infections

July 1, 2005

BiDil approved for treatment of heart failure in black patients

June 28, 2005

Accelerated approval for Aptivus in HIV

June 23, 2005

Tygacil receives FDA approval

June 17, 2005

Enbrel approved to improve physical function in psoriatic arthritis

June 2, 2005

FDA approval for Naglazyme

June 2, 2005

New approval for Arixtra

May 31, 2005

Remicade approved for psoriatic arthritis

May 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...